Publications by authors named "Kelly E Rowe"

Claim this Profile
M
Management of Severe Hemiballismus: Treatment Challenges in the Acute Inpatient Rehabilitation Setting: A Case Presentation.
Michael Hodde, Kelly E Rowe, Krishna Surapaneni, Phillip Terrigno, Anthony Brighenti

PM R· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poster 327 The Tribulations, Trials, and Triumphs of Treating and Rehabilitating Hemiballismus: A Case Report.
Michael Hodde, Kelly E Rowe, Eric Altschuler

PM R· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats.
Jesse R Schank, Jenica D Tapocik, Estelle Barbier, Ruslan Damadzic, Robert L Eskay, Kelly E Rowe

Biol Psychiatry· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety.
Jesse R Schank, Andrea L Goldstein, Kelly E Rowe, Courtney E King, Julie A Marusich

Addict Biol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429.
Jesse R Schank, Charles L Pickens, Kelly E Rowe, Kejun Cheng, Annika Thorsell

Psychopharmacology (Berl)· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis